| IPT Week 2 AceI |
IPT Week 2 Ace Inhibitors |
Unfinished |
2023-03-10 |
LDM |
11 |
0 |
edit |
|
| IPT Module 2 ARA's |
Angiotensin Receptor Antagonists |
Unfinished |
2023-03-10 |
LDM |
6 |
0 |
edit |
|
| Schedule 8's |
Schedule 8's |
Unfinished |
2023-05-10 |
LDM |
27 |
0 |
edit |
|
| Trusting Relations |
Building Trusting Relationships PP3 |
Unfinished |
2023-05-12 |
LDM |
23 |
0 |
edit |
|
| 7CPA + Services |
7th Community Pharmacy Agreement+ Professional Pharmacy Services |
Unfinished |
2023-05-13 |
LDM |
14 |
0 |
edit |
|
| Pharmacy Services |
Professional Pharmacy Services |
Unfinished |
2023-05-13 |
LDM |
11 |
0 |
edit |
|
| Pharmacy Services |
Pharmacy Professional Services |
Unfinished |
2023-05-13 |
LDM |
28 |
0 |
edit |
|
| S2 and S3 Medicines |
S2/S3 Meds and Legal Requirements |
Unfinished |
2023-05-15 |
LDM |
19 |
0 |
edit |
|
| Clinic Intervention |
Clinical Interventions |
Unfinished |
2023-05-15 |
LDM |
9 |
0 |
edit |
|
| Bioequiivalence |
Bioequivalence and generic medicines |
Unfinished |
2023-05-15 |
LDM |
11 |
0 |
edit |
|
| Intro Sterile Comp |
Introduction to Sterile Compounding |
Unfinished |
2023-05-22 |
LDM |
9 |
0 |
edit |
|
| HTN Management |
Management of Hypertension |
Unfinished |
2023-05-29 |
LDM |
14 |
0 |
edit |
|
| Management RA |
Management of Rheumatoid Arthritis |
Pharmacology |
2023-08-16 |
LDM |
28 |
0 |
edit |
|
| RA Pharmacology |
Pharmacology of drugs used in RA |
Pharmacology |
2023-09-13 |
LDM |
39 |
0 |
edit |
|
| Osteo Pharmacology |
Pharmacology for Osteo Arthritis |
Unfinished |
2023-08-18 |
LDM |
11 |
0 |
edit |
|
| Eye Drop Formulation |
Pharm Tech Sterility Eye drop formulation |
Unfinished |
2023-08-30 |
LDM |
28 |
0 |
edit |
|
| Asthma pathophys |
Asthma Pathophysiology |
Pharmacology |
2023-08-21 |
LDM |
20 |
0 |
edit |
|
| Asthma pharmacology |
Asthma medicine pharmacology |
Pharmacology |
2023-09-12 |
LDM |
40 |
0 |
edit |
|
| Recombinant Pharma 1 |
Biopharmaceuticals 1 |
Pharmacology |
2023-08-29 |
LDM |
27 |
0 |
edit |
|
| Recombinant 2 |
Immunotherapy |
Pharmacology |
2023-08-29 |
LDM |
24 |
0 |
edit |
|
| Colligatives |
Colligative Properties 1 and 2 |
Pharmacology |
2023-08-31 |
LDM |
35 |
0 |
edit |
|
| RA Drugs |
Doses, ADR's, C/I's, other little details |
Unfinished |
2023-09-08 |
LDM |
52 |
0 |
edit |
|
| Asthma management |
Guide to asthma management in adults |
Unfinished |
2023-09-09 |
LDM |
25 |
0 |
edit |
|
| Asthma M in Children |
Asthma management in children |
Unfinished |
2023-09-10 |
LDM |
11 |
0 |
edit |
|
| Special Asthma Manag |
Special cases of asthma management |
Unfinished |
2023-09-10 |
LDM |
7 |
0 |
edit |
|
| Gout Pharm + Path |
Pathophysiology of Gout and Pharmacology |
Pharmacology |
2023-09-12 |
LDM |
34 |
0 |
edit |
|
| Gout Management |
Pharmacotherapy for gout management |
Pharmacology |
2023-09-12 |
LDM |
44 |
0 |
edit |
|
| OA Management |
Management of Osteo Arthritis |
Pharmacology |
2023-09-13 |
LDM |
25 |
0 |
edit |
|
| COPD Pharmacol |
Pharmacology of drugs used in COPD |
Pharmacology |
2023-09-13 |
LDM |
28 |
0 |
edit |
|
| COPD Management |
COPD management |
Unfinished |
2023-09-13 |
LDM |
26 |
0 |
edit |
|
| CAP management |
Management of Community Acquired Pneumonia |
Pharmacology |
2023-09-14 |
LDM |
30 |
0 |
edit |
|
| HAP Management |
Hospital Acquired Pneumonia Management |
Unfinished |
2023-09-14 |
LDM |
13 |
0 |
edit |
|
| DVT and PE |
Deep Vein Thrombosis and Pulmonary Embolism |
Unfinished |
2023-09-14 |
LDM |
24 |
0 |
edit |
|
| Clinical Case Study |
PP4 clinical case study lecture review |
Unfinished |
2023-09-26 |
LDM |
7 |
0 |
edit |
|
| Governance of HP |
Governance of Hospital Pharmacy Practice |
Pharmacology |
2023-09-28 |
LDM |
35 |
0 |
edit |
|
| Clinical Handover |
PP4 Clinical Handover and Isobar |
Pharmacology |
2023-09-28 |
LDM |
15 |
0 |
edit |
|
| Pharmacoeconomics |
PP4 Pharmacoecnomics and Med Formulary |
Pharmacology |
2023-09-29 |
LDM |
30 |
0 |
edit |
|
| Med Rec Theory |
PP4 Med Rec Theory |
Pharmacology |
2023-09-30 |
LDM |
25 |
0 |
edit |
|
| Med Charts |
PP4 Standardised Med Charts |
Unfinished |
2023-09-30 |
LDM |
7 |
0 |
edit |
|
| PBS reform |
PP4 PBS reform and Dispensing in Hospital |
Unfinished |
2023-10-01 |
LDM |
32 |
0 |
edit |
|
| Procurement |
PP4 Hospital Procurement and Med Supply Chain |
Unfinished |
2023-10-01 |
LDM |
28 |
0 |
edit |
|
| Medication Safety |
PP4 Medication Safety Lecture |
Pharmacology |
2023-10-03 |
LDM |
17 |
0 |
edit |
|
| Clinical Decisions |
PP4 Clinical Decision Making |
Pharmacology |
2023-10-03 |
LDM |
7 |
0 |
edit |
|
| Prioritisation |
PP4 Prioritisation Clinical Decisions |
Pharmacology |
2023-10-04 |
LDM |
9 |
0 |
edit |
|
| Membrane Filtration |
Sterilisation by Membrane Filtration |
Pharmacology |
2023-11-05 |
LDM |
24 |
0 |
edit |
|
| Cold Sterilisation |
Cold Sterilisation |
Pharmacology |
2023-11-05 |
LDM |
26 |
0 |
edit |
|
| Sterility Testing |
Sterility Testing |
Pharmacology |
2023-11-06 |
LDM |
40 |
0 |
edit |
|
| Parametic release |
Parametric release |
Pharmacology |
2023-11-06 |
LDM |
23 |
0 |
edit |
|
| CDR and TPN |
Cytotixic Drug Reconstitution and Total Parenteral Nutrition |
Unfinished |
2023-11-06 |
LDM |
28 |
0 |
edit |
|
| Protein and Insulin |
Protein formulation and insulin |
Pharmacology |
2023-11-06 |
LDM |
32 |
0 |
edit |
|
| Beta Lactams |
Beta Lactams 1 |
Unfinished |
2024-01-01 |
LDM |
42 |
0 |
edit |
|
| Sulfonamides/Trimeth |
Sulfonamides/Trimeth |
Unfinished |
2024-01-05 |
LDM |
27 |
0 |
edit |
|
| Dep Disorder Intro |
Depressive Disorder Intro |
Unfinished |
2024-03-18 |
LDM |
18 |
0 |
edit |
|
| CNS Pharm Intro |
CNS Pharmacology Introduction |
Unfinished |
2024-03-24 |
LDM |
8 |
0 |
edit |
|
| TCA's |
Monograph Q's |
Unfinished |
2024-04-05 |
LDM |
12 |
0 |
edit |
|
| SSRI's |
SSRI's |
Unfinished |
2024-04-06 |
LDM |
11 |
0 |
edit |
|
| NRI/SNRI |
NRI/SNRI's |
Unfinished |
2024-04-07 |
LDM |
7 |
0 |
edit |
|
| MAOI's |
MAOI's |
Unfinished |
2024-04-07 |
LDM |
6 |
0 |
edit |
|
| RIMA's |
Reverisble MAO-A Inhibitor |
Unfinished |
2024-04-07 |
LDM |
7 |
0 |
edit |
|
| Depression Mngt |
Management of Depression |
Unfinished |
2024-04-07 |
LDM |
28 |
0 |
edit |
|
